Inhibitors |
|
---|---|
Cat No | Product Name / Activity |
5258 | BMS 309403 |
Potent and selective FABP4 inhibitor | |
5762 | BMS 795311 |
Potent cholesteryl ester transfer protein (CETP) inhibitor | |
6319 | CBM 301940New |
Potent malonyl-CoA decarboxylase inhibitor; orally bioavailable | |
5850 | HM 50316 |
High affinity FABP4 inhibitor | |
5631 | LDN 193188 |
Inhibitor of phosphatidylcholine transfer protein (PC-TP) | |
5790 | PF 05175157 |
Acetyl-CoA carboxylase (ACC) 1 and 2 inhibitor | |
1842 | RHC 80267 |
Diacylglycerol lipase inhibitor | |
5389 | Ro 48-8071 fumarate |
2,3-Oxidosqualene cyclase (OSC) inhibitor; blocks cholesterol synthesis | |
4189 | SC 26196 |
Selective FADS2 inhibitor | |
6106 | T 3364366New |
Potent and reversible FADS1 inhibitor; orally bioavailable | |
4184 | Torcetrapib |
Inhibitor of cholesteryl ester transfer protein (CETP) | |
5259 | WWL 113 |
Ces3 and Ces1f inhibitor | |
Other |
|
Cat No | Product Name / Activity |
0355 | (±)-Acetylcarnitine chloride |
Intermediate in lipid metabolism | |
2784 | Acipimox |
Antilipolytic agent | |
2756 | Arachidonic acid (in Tocrisolve™100) |
Endogenous free fatty acid (in water-soluble emulsion) | |
0477 | (±)-Decanoylcarnitine chloride |
Intermediate in lipid metabolism | |
4378 | DLPC |
LRH-1 agonist; regulates bile acid metabolism | |
0526 | (±)-Hexanoylcarnitine chloride |
Intermediate in lipid metabolism | |
0548 | (±)-Lauroylcarnitine chloride |
Intermediate in lipid metabolism | |
0567 | (±)-Myristoylcarnitine chloride |
Intermediate in lipid metabolism | |
0605 | (±)-Octanoylcarnitine chloride |
Intermediate in lipid metabolism | |
0878 | Oleamide |
Sleep-inducing brain lipid | |
1484 | Oleylethanolamide |
Lipid mediator, anorexic actions; also GPR55 and PPARα agonist | |
0609 | (±)-Palmitoylcarnitine chloride |
Intermediate in fatty acid oxidation | |
0611 | (±)-Propionylcarnitine chloride |
Intermediate in lipid metabolism |